RT Journal Article
SR Electronic
T1 Clopidogrel and thrombotic thrombocytopenic purpura: No clear case for causality
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 466
OP 470
VO 70
IS 5
A1 Majhail, Navneet S.
A1 Lichtin, Alan E.
YR 2003
UL http://www.ccjm.org/content/70/5/466.abstract
AB Although the antiplatelet agent clopidogrel is associated with an increased incidence of thrombotic thrombocytopenic purpura (TTP), available evidence is not sufficient to establish or disprove a causal relationship. We review and assess the evidence and case reports linking clopidogrel use with TTP and discuss how to approach the risk of TTP in patients taking clopidogrel.